Immunic OverviewImmunic Net Income
Profitability analysis for IMUX.
Quarterly Net Income
-$32.59M
↓ 27.93% YoY
As of Mar 2026
Annual Net Income (TTM)
-$104.29M
↓ 8.19% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...